SPDR S&P Biotech ETF $XBI Shares Newly Acquired by Moss Adams Wealth Advisors LLC

Moss Adams Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 195,591 shares of the exchange traded fund’s stock, valued at approximately $30,841,000. SPDR S&P Biotech ETF accounts for about 2.0% of Moss Adams Wealth Advisors LLC’s portfolio, making the stock its 11th largest holding. Moss Adams Wealth Advisors LLC owned 0.29% of SPDR S&P Biotech ETF as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the business. Axiom Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at $26,000. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $28,000. Root Financial Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $31,000. Morling Financial Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $36,000. Finally, Ascentis Independent Advisors acquired a new position in SPDR S&P Biotech ETF in the first quarter valued at $42,000.

SPDR S&P Biotech ETF Trading Down 1.1%

SPDR S&P Biotech ETF stock opened at $155.98 on Friday. The stock has a 50 day moving average of $156.60 and a two-hundred day moving average of $141.58. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The stock has a market capitalization of $10.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.